Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BCI-121是一种底物竞争性 SMYD3 抑制剂,可抑制癌细胞的增殖。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 247 | 现货 | ||
5 mg | ¥ 559 | 现货 | ||
10 mg | ¥ 898 | 现货 | ||
25 mg | ¥ 1,980 | 现货 | ||
50 mg | ¥ 2,970 | 现货 | ||
100 mg | ¥ 4,380 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 559 | 现货 |
产品描述 | BCI-121 is a substrate-competitive SMYD3 inhibitor that inhibits the proliferation of the cancer cell. |
体外活性 | BCI-121 significantly reduced the proliferation of HT29 (by 46%) and HCT116 (by 54%) cells at 72 h and decreased the expression levels of SMYD3 target genes. BCI-121 treatment only affected proliferation of cancer cell lines expressing high levels of SMYD3. The high levels of SMYD3 expression detected in OVCAR-3 cells, along with the strong reduction in proliferation rate observed upon BCI-121 treatment. |
细胞实验 | Cell proliferation is determined using the cell proliferation reagent WST-1. Cells are seeded into 96-well plates one day before treatment. After 48 h, 72 h, or 96 h of BCI-121 or DMSO exposure, 10 μL of the Cell Proliferation Reagent WST-1 are added to each well and incubated at 37 °C in a humidified incubator for up to 1 h. Absorbance is measured on a microplate reader at 450/655 nm. The proliferation index is calculated as the ratio of WST-1 absorbance of treated cells to WST-1 absorbance of control cells. |
分子量 | 340.22 |
分子式 | C14H18BrN3O2 |
CAS No. | 432529-82-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (293.93 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.9393 mL | 14.6964 mL | 29.3927 mL | 73.4819 mL |
5 mM | 0.5879 mL | 2.9393 mL | 5.8785 mL | 14.6964 mL | |
10 mM | 0.2939 mL | 1.4696 mL | 2.9393 mL | 7.3482 mL | |
20 mM | 0.147 mL | 0.7348 mL | 1.4696 mL | 3.6741 mL | |
50 mM | 0.0588 mL | 0.2939 mL | 0.5879 mL | 1.4696 mL | |
100 mM | 0.0294 mL | 0.147 mL | 0.2939 mL | 0.7348 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BCI-121 432529-82-3 Chromatin/Epigenetic Histone Methyltransferase inhibit BCI121 Inhibitor BCI 121 inhibitor